Cargando…
Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
BACKGROUND: Affective and interpersonal behavioural patterns characteristic of social anxiety disorder show improvement during treatment with serotonin agonists (e.g., selective serotonin reuptake inhibitors), commonly used in the treatment of social anxiety disorder. The present study sought to est...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955850/ https://www.ncbi.nlm.nih.gov/pubmed/33026311 http://dx.doi.org/10.1503/jpn.190164 |
_version_ | 1783664327401668608 |
---|---|
author | Rappaport, Lance M. Hunter, Michael D. Russell, Jennifer J. Pinard, Gilbert Bleau, Pierre Moskowitz, D.S. |
author_facet | Rappaport, Lance M. Hunter, Michael D. Russell, Jennifer J. Pinard, Gilbert Bleau, Pierre Moskowitz, D.S. |
author_sort | Rappaport, Lance M. |
collection | PubMed |
description | BACKGROUND: Affective and interpersonal behavioural patterns characteristic of social anxiety disorder show improvement during treatment with serotonin agonists (e.g., selective serotonin reuptake inhibitors), commonly used in the treatment of social anxiety disorder. The present study sought to establish whether, during community psychopharmacological treatment of social anxiety disorder, changes in positive or negative affect and agreeable or quarrelsome behaviour mediate improvement in social anxiety symptom severity or follow from it. METHODS: Adults diagnosed with social anxiety disorder (n = 48) recorded their interpersonal behaviour and affect naturalistically in an event-contingent recording procedure for 1-week periods before and during the first 4 months of treatment with paroxetine. Participants and treating psychiatrists assessed the severity of social anxiety symptoms monthly. A multivariate latent change score framework examined temporally lagged associations of change in affect and interpersonal behaviour with change in social anxiety symptom severity. RESULTS: Elevated agreeable behaviour and positive affect predicted greater subsequent reduction in social anxiety symptom severity over the following month of treatment. Elevated negative affect, but not quarrelsome behaviour, predicted less subsequent reduction in symptom severity. LIMITATIONS: Limitations included limited assessment of extreme behaviour (e.g., violence) that may have precluded examining the efficacy of paroxetine because of the lack of a placebo control group. CONCLUSION: The present study suggests that interpersonal behaviour and affect may be putative mechanisms of action for serotonergic treatment of social anxiety disorder. Prosocial behaviour and positive affect increase during serotonergic treatment of social anxiety disorder. Specifically, modulating agreeable behaviour, positive affect and negative affect in individuals’ daily lives may partially explain and refine clinical intervention. |
format | Online Article Text |
id | pubmed-7955850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Joule Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79558502021-03-19 Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder Rappaport, Lance M. Hunter, Michael D. Russell, Jennifer J. Pinard, Gilbert Bleau, Pierre Moskowitz, D.S. J Psychiatry Neurosci Research Paper BACKGROUND: Affective and interpersonal behavioural patterns characteristic of social anxiety disorder show improvement during treatment with serotonin agonists (e.g., selective serotonin reuptake inhibitors), commonly used in the treatment of social anxiety disorder. The present study sought to establish whether, during community psychopharmacological treatment of social anxiety disorder, changes in positive or negative affect and agreeable or quarrelsome behaviour mediate improvement in social anxiety symptom severity or follow from it. METHODS: Adults diagnosed with social anxiety disorder (n = 48) recorded their interpersonal behaviour and affect naturalistically in an event-contingent recording procedure for 1-week periods before and during the first 4 months of treatment with paroxetine. Participants and treating psychiatrists assessed the severity of social anxiety symptoms monthly. A multivariate latent change score framework examined temporally lagged associations of change in affect and interpersonal behaviour with change in social anxiety symptom severity. RESULTS: Elevated agreeable behaviour and positive affect predicted greater subsequent reduction in social anxiety symptom severity over the following month of treatment. Elevated negative affect, but not quarrelsome behaviour, predicted less subsequent reduction in symptom severity. LIMITATIONS: Limitations included limited assessment of extreme behaviour (e.g., violence) that may have precluded examining the efficacy of paroxetine because of the lack of a placebo control group. CONCLUSION: The present study suggests that interpersonal behaviour and affect may be putative mechanisms of action for serotonergic treatment of social anxiety disorder. Prosocial behaviour and positive affect increase during serotonergic treatment of social anxiety disorder. Specifically, modulating agreeable behaviour, positive affect and negative affect in individuals’ daily lives may partially explain and refine clinical intervention. Joule Inc. 2021-01 /pmc/articles/PMC7955850/ /pubmed/33026311 http://dx.doi.org/10.1503/jpn.190164 Text en © 2021 Joule Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is non-commercial (i.e. research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Research Paper Rappaport, Lance M. Hunter, Michael D. Russell, Jennifer J. Pinard, Gilbert Bleau, Pierre Moskowitz, D.S. Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder |
title | Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder |
title_full | Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder |
title_fullStr | Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder |
title_full_unstemmed | Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder |
title_short | Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder |
title_sort | emotional and interpersonal mechanisms in community ssri treatment of social anxiety disorder |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955850/ https://www.ncbi.nlm.nih.gov/pubmed/33026311 http://dx.doi.org/10.1503/jpn.190164 |
work_keys_str_mv | AT rappaportlancem emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder AT huntermichaeld emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder AT russelljenniferj emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder AT pinardgilbert emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder AT bleaupierre emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder AT moskowitzds emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder |